7 results match your criteria: "Arthur James Cancer Hospital & Research Institute[Affiliation]"
Anaesth Crit Care Pain Med
October 2023
Lyon University Hospital, Department of Anaesthesiology and Critical Care, IHU EVEREST, Croix Rousse University Hospital, Hospices Civils de Lyon, Lyon, France; INSERM U1052, Cancer Research Center of Lyon, Lyon, France.
Ann Surg Oncol
November 2022
Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Introduction: Small intestinal neuroendocrine tumors (SI-NETs) often present with metastatic disease. An ongoing debate exists on whether to perform primary tumor resection (PTR) in patients with stage IV SI-NETs, without symptoms of the primary tumor and inoperable metastatic disease.
Objective: The aim of this study was to compare a treatment strategy of upfront surgical resection versus a surveillance strategy of watch and wait.
Anaesth Crit Care Pain Med
June 2022
Department of Anaesthesiology and Obstetric Critical Care Unit, University Maternity Hospital of Nancy, 54000 Nancy, France; Past President of the French Society of Anaesthesia and Intensive Care Medicine (SFAR), Paris, France.
J Laparoendosc Adv Surg Tech A
November 2020
Department of General Surgery, Liverpool University Hospitals NHS Foundation Trust, Aintree University Hospital, University of Liverpool, Liverpool, United Kingdom.
Patients with colorectal cancer deemed to be high-risk may be denied an elective laparoscopic resection due to subjective reasons. A comparison of the 30-day outcomes in true functional high-risk patients who underwent either open or laparoscopic colorectal resection was undertaken. A retrospective cohort of all functional high-risk patients as assessed by cardiopulmonary exercise test between July 2015 and April 2018 were identified.
View Article and Find Full Text PDFGut
February 2019
Department of Colorectal Surgery, Cambridge University Hospitals, Cambridge, UK.
Objective: Lack of standardised outcomes hampers effective analysis and comparison of data when comparing treatments in fistulising perianal Crohn's disease (pCD). Development of a standardised set of outcomes would resolve these issues. This study provides the definitive core outcome set (COS) for fistulising pCD.
View Article and Find Full Text PDFJ Food Drug Anal
July 2017
Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Taiwan; Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan; Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address:
J Food Drug Anal
January 2017
Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Prosopis is a commercially important plant genus, which has been used since ancient times, particularly for medicinal purposes. Traditionally, Paste, gum, and smoke from leaves and pods are applied for anticancer, antidiabetic, anti-inflammatory, and antimicrobial purposes. Components of Prosopis such as flavonoids, tannins, alkaloids, quinones, or phenolic compounds demonstrate potentials in various biofunctions, such as analgesic, anthelmintic, antibiotic, antiemetic, microbial antioxidant, antimalarial, antiprotozoal, antipustule, and antiulcer activities; enhancement of H, K, ATPases; oral disinfection; and probiotic and nutritional effects; as well as in other biopharmaceutical applications, such as binding abilities for tablet production.
View Article and Find Full Text PDF